<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>30(8)</volume><submitter>Freeman CL</submitter><funding>NCI NIH HHS</funding><journal>Leukemia</journal><pagination>1763-6</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4980557</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Role of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumab.</pubmed_title><pmcid>PMC4980557</pmcid><funding_grant_id>P01 CA081534</funding_grant_id><pubmed_authors>Kreuzer KA</pubmed_authors><pubmed_authors>Fingerle-Rowson G</pubmed_authors><pubmed_authors>Humphrey K</pubmed_authors><pubmed_authors>Gribben J</pubmed_authors><pubmed_authors>Hallek M</pubmed_authors><pubmed_authors>Iglesias V</pubmed_authors><pubmed_authors>Goede V</pubmed_authors><pubmed_authors>de Costa CS</pubmed_authors><pubmed_authors>Houghton R</pubmed_authors><pubmed_authors>Herling M</pubmed_authors><pubmed_authors>Dixon M</pubmed_authors><pubmed_authors>Stilgenbauer S</pubmed_authors><pubmed_authors>Bottcher S</pubmed_authors><pubmed_authors>Freeman CL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Role of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumab.</name><description/><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Aug</publication><modification>2026-04-15T17:27:47.987Z</modification><creation>2024-11-12T19:21:30.58Z</creation></dates><accession>S-EPMC4980557</accession><cross_references><pubmed>26979130</pubmed><doi>10.1038/leu.2016.41</doi></cross_references></HashMap>